No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Beijing Scitop Bio-tech Co., Ltd. operates in China, specializing in the research, production, and sale of probiotic lactic acid bacteria and their related derivatives. The company's product range also encompasses complex food additives, consumer-grade probiotic items, and specialized microecological preparations for both animal and plant applications. These diverse solutions are utilized across various industries, including food processing, healthcare, livestock farming, and crop cultivation. Founded in 2003, Beijing serves as the company's main operational hub.
www.scitop.cnNo one on the platform currently holds 300858.SZ.
No tracked institution reports a position in 300858.SZ as of their last filing.
No one on the platform has traded 300858.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 3.8% | — | — | — | ||
| Rev. Growth % | 20.0% | 1.4% | ||||
| Profit Margin % | 26.0% | 29.6% | 26.5% | |||
| Free Cash Flow Margin % | -47.5% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $534M | +22.8% | $0.59 | $0.59–$0.59 | — | 1 |
| 2027 | $629M | +17.9% | $0.69 | $0.69–$0.69 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300858.SZBeijing Scitop Bio-tech Co., Ltd. | $14.26 | +0.42% | $3.8B | — |
| 002868.SZLifecome Biochemistry Co.,Ltd. | $22.82 | +0.31% | $3.5B | — |
| 300871.SZHvsen Biotechnology Co., Ltd. | $21.44 | -0.56% | $4.3B | — |
| 300942.SZShenzhen Bioeasy Biotechnology Co., Ltd. | $6.30 | +1.12% | $2.6B | — |
| 603439.SSGuiZhou SanLi Pharmaceutical Co.,Ltd | $13.19 | -6.45% | $5.3B | — |
| 603566.SSPulike Biological Engineering, Inc. | $10.11 | +0.20% | $3.5B | — |
| 603718.SSShanghai Hile Bio-Technology Co., Ltd. | $3.04 | +1.00% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry